Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can PET-CT scans better predict breast cancer treatment success?

NCT ID NCT07173868

Recruiting now Knowledge-focused Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether a special type of PET-CT scan (F-18 FDG PET-CT) can better track how well treatment is working in people with advanced breast cancer compared to standard imaging like CT scans. Researchers will follow 100 patients for 48 weeks after they start their first systemic therapy. The goal is to see if the PET-CT scan gives a clearer picture of treatment response, which could help doctors make better decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

F-18 FDG PET-CT imaging

What this could lead to

If successful, this could show that PET-CT scans are better than standard imaging at predicting outcomes, potentially guiding more personalized treatment decisions.

What could go wrong

This is an observational study with only 100 participants, so results may not apply to all patients. It compares imaging methods, not treatments, so it won't directly improve outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HISTOLOGICALLY CONFIRMED METASTATIC OR LOCALLY ADVANCED BREAST CANCER WITH NO RADICAL TOPICAL TREATMENT AVAILABLE IF THERE IS LIVER METASTASIS, WHICH THE RESEARCHER BELIEVES WILL BE DIFFICULT TO EVALUATE THE RESPONSE ACCURATELY WITH BONE METASTASIS OR CT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Samsung medical Center

    RECRUITING

    Seoul, Gannam-gu, 06351, South Korea